ENJ Operating Income
$3.09BTTM · USD
Period ending:
ENJ FY Operating IncomeUSD
$3.20B$0.00
2003-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
ENJ operating income history
Profit from core business operations before interest and taxes. The available annual fiscal periods series contains 23 observations from Dec 31, 2003 to Dec 31, 2025.
| Period ending | Operating Income (USD) |
|---|---|
| 3,202,278,000 | |
| 2,651,090,000 | |
| 71,864,000 | |
| 121,126,000 | |
| 1,845,626,000 | |
| 64,412,000 | |
| 68,685,000 | |
| 74,192,000 | |
| 96,409,000 | |
| 100,893,000 | |
| 84,970,000 | |
| 57,956,000 | |
| 30,770,000 | |
| 35,890,000 | |
| 2,013,234,000 | |
| 2,267,377,000 | |
| 2,284,526,000 | |
| 2,283,167,000 | |
| 2,056,368,000 | |
| 1,805,360,000 | |
| 1,791,989,000 | |
| 1,653,564,000 | |
| 0 |
Compare operating income
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) operating income
- HSBC Holdings, plc. Common Stock (HSBC) operating income
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) operating income
- Novartis AG Common Stock (NVS) operating income
- Royal Bank Of Canada Common Stock (RY) operating income
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) operating income
- SAP SE ADS (SAP) operating income
- AstraZeneca PLC Ordinary Shares (AZN) operating income
All ENJ financial metrics · ENJ stock overview · How to interpret financial metrics
